Cell proliferation in the bronchial mucosa of asthmatics and chronic bronchitics

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Respiratory Pathology

Background:

• Cellular proliferation in the bronchial epithelium is a key factor in chronic inflammatory diseases.
• While normal bronchial epithelium has low cell cycling, asthma and chronic bronchitis may involve increased proliferation.
• Proliferating Cell Nuclear Antigen (PCNA) is a biomarker for identifying cycling cells.

Purpose of the Study:

• To quantify Proliferating Cell Nuclear Antigen (PCNA)-positive cells in bronchial biopsies across different subject groups.
• To investigate the relationship between smoking, asthma, chronic bronchitis, and bronchial epithelial cell proliferation.
• To determine if bronchial mucosa exhibits hyperproliferation in non-smokers, even with asthma.

Main Methods:

• Immunohistochemistry was used to detect PCNA-positive cells in bronchial biopsies.
• Labeling Index (LI) was calculated for basal cells in healthy non-smokers, healthy smokers, non-smoking asthmatics, smoking asthmatics, and chronic bronchitis patients.
• Statistical analysis, including correlation tests, was performed to assess relationships between PCNA positivity and clinical factors.

Main Results:

• PCNA-positive basal cells were found in 1/11 healthy non-smokers, 0/7 healthy smokers, 2/30 non-smoking asthmatics, 2/6 smoking asthmatics, and 11/18 chronic bronchitis patients.
• PCNA positivity in smokers correlated with tobacco consumption (Rho = 0.62).
• In chronic bronchitis patients, PCNA positivity correlated with the degree of metaplasia (tau = 0.815).

Conclusions:

• Bronchial mucosa in non-smokers, including asthmatics, does not appear to be hyperproliferative.
• Tobacco smoking significantly increases bronchial epithelial cell proliferation (PCNA immunoreactivity).
• Increased proliferation due to smoking may contribute to the metaplasia observed in chronic bronchitis.